FDA flags safety risk with Boston Scientific stents
The FDA has classified Boston Scientific’s removal of certain Axios Stent and Electrocautery-Enhanced Delivery Systems as a Class I recall, the agency’s most serious designation. The recall stems from increased reports of deployment and expansion issues during stent placement. As of Dec. 23, three deaths and 167 serious injuries had been reported in connection with […]
Continue Reading